Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases
A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.
​​​​​​​Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients
Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), for research on reducing inflammation and lung damage in acute respiratory distress syndrome (ARDS) patients.
Multiple myeloma drug shows efficacy in treating rare bleeding disorder
A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder.
FIND Lp(a) machine learning model aims to transform cardiovascular disease screening
Today, the Family Heart Foundation®, a leading research and advocacy organization, announced the successful completion of the Flag, Identify, Network and Deliver™ “FIND Lp(a)” machine learning model – a first-of-its-kind offering being implemented in care delivery systems across the United States.
Philanthropic investment establishes research center to advance precision diagnosis for diseases
An outstanding $21 million philanthropic investment will establish a pioneering research center to advance precision diagnosis for diseases that affect millions of Australians.
Eat more fruit and vegetables to lower frailty risk
Research finds that higher intake of fruits and vegetables significantly lowers frailty risk, especially in underweight individuals. Whole fruits and red-orange vegetables offer the greatest protective effects.
Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients
Researchers confirm plasma pTau181 is a strong predictor for Alzheimer's in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.
Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk
Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at risk of Alzheimer’s disease.
last updated on 20 Sep 10:42